RxDoctor Payments DataLook up a doctor →

Kristin Press

Acute Care · Chesterfield, MONPI 1174884209

Payments from drug & device makers

$13,853in general payments, 2019–2025

Across 849 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Pfizer$1K
  • UCB, Inc.$551
  • Lundbeck LLC$514
  • Lilly USA, LLC$491
  • Novartis$416
  • plus $6K from 47 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)280$4,950
Pfizer189$1,177
UCB, Inc.24$551
Lundbeck LLC18$514
Lilly USA, LLC25$491
Novartis24$416
Teva Pharmaceuticals USA, Inc.21$385
Amgen18$340
Biogen13$271
AstraZeneca(2 entities)14$268
Amneal Pharmaceuticals LLC12$240
CSL Behring9$235
Acadia Pharmaceuticals Inc13$231
Neurelis, Inc.12$229
Eisai Inc.11$227
Biohaven Pharmaceutical Holding Company Ltd.21$220
EMD Serono, Inc.11$218
Johnson & Johnson10$193
SK Life Science, Inc.10$192
Axsome Therapeutics, Inc.6$181
Medtronic7$176
Grifols USA, LLC8$172
Upsher-smith Laboratories LLC7$149
Boston Scientific4$143
Sanofi6$142
Neurocrine Biosciences, Inc.5$133
Microtransponder, Inc.2$125
Argenx US, Inc.5$115
Tanabe Pharma America, Inc.5$101
Takeda Pharmaceuticals U.S.A., Inc.3$80
Arbor Pharmaceuticals, Inc.5$76
Jazz Pharmaceuticals Inc.2$72
Catalyst Pharmaceuticals, Inc.3$64
Avion Pharmaceuticals4$64
Abbott3$62
Acorda Therapeutics, Inc4$62
Genentech USA, Inc.4$59
Banner Life Sciences, LLC3$56
Corium, LLC3$51
GE HealthCare3$50
Azurity Pharmaceuticals, Inc.3$42
Currax Pharmaceuticals LLC3$41
Biohaven Pharmaceuticals, Inc.2$37
Impel Pharmaceuticals Inc.2$36
Sumitomo Pharma America, Inc.2$34
Supernus Pharmaceuticals, Inc.2$32
Kyowa Kirin, Inc.2$27
TG Therapeutics, Inc.1$22
Merz Pharmaceuticals, LLC1$21
Life Molecular Imaging Ltd1$21
Alnylam Pharmaceuticals Inc.1$20
Vertex1$20
Xeris Pharmaceuticals, Inc.1$16

How this compares

$13,853 in reported general payments places this provider in the 95th percentile of 272 acute care providers in Missouri.

See all acute care providers in Missouri →

Medicare billing

Part B allowed, 2024
$198,096
Medicare patients
502
Services billed
19,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Chesterfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →